Stay updated with breaking news from Remunity Pump. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LSV Asset Management raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 383,068 shares of the biotechnology company’s stock after acquiring an additional 3,700 shares during the […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given an average recommendation of “Buy” by the eight research firms that are currently covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued a […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given a consensus rating of “Buy” by the eight research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have covered the stock in the last […]
Forsta AP Fonden lessened its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 70.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,500 shares of the biotechnology company’s stock after selling 5,900 shares during the period. Forsta AP […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 4th. The shares were sold at an average price of $227.97, for a total transaction of $1,367,820.00. Following the completion of the transaction, the executive vice president now […]